Clinical Trial Update: A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, pharmacokinetics, and drug-drug interaction of LT3001 in healthy subjects. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• LT3001

Snippet

Sponsor: Lumosa Therapeutics Co., Ltd. | Conditions: Acute Ischemic Stroke | Phase 1 | Status: COMPLETED | Results posted: 2026-02-06